About
Celine Halioua is the CEO of Cellectis, a biotechnology company focused on gene editing technologies using tools like CRISPR and TALENs. She is a leader in the synthetic biology field, driving innovation in genome engineering.
Celine Halioua is the CEO of Cellectis, a biotechnology company focused on gene editing technologies using tools like CRISPR and TALENs. She is a leader in the synthetic biology field, driving innovation in genome engineering.
